Filing Details
- Accession Number:
- 0001209191-11-052489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-24 16:54:53
- Reporting Period:
- 2011-10-20
- Filing Date:
- 2011-10-24
- Accepted Time:
- 2011-10-24 16:54:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1128495 | Anadys Pharmaceuticals Inc | ANDS | Pharmaceutical Preparations (2834) | 223193172 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1290165 | Qvt Fund Lp | Walkers Spv, Walker House 87 Mary Street Georgetown, Grand Cayman E9 KY1-9005 | No | No | Yes | No | |
1290166 | Qvt Associates Gp Llc | 1177 Avenue Of The Americas 9Th Floor New York NY 10036 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Disposition | 2011-10-20 | 5,252,700 | $3.68 | 5,517,854 | No | 4 | S | Indirect | Through QVT Fund LP and Quintessence Fund L.P. |
Common Stock, $0.001 Par Value | Disposition | 2011-10-21 | 364,918 | $3.68 | 5,152,936 | No | 4 | S | Indirect | Through QVT Fund LP and Quintessence Fund L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Through QVT Fund LP and Quintessence Fund L.P. |
No | 4 | S | Indirect | Through QVT Fund LP and Quintessence Fund L.P. |